[Federal Register Volume 82, Number 111 (Monday, June 12, 2017)]
[Notices]
[Pages 26933-26934]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-12123]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Secondary Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the secondary review of 
applications in response to Funding Opportunity Announcements (FOAs), 
CE17-003, Research Grants for Preventing Violence and Violence Related 
Injury (R01); and PHS 2016-02 Omnibus Solicitation of the NIH, CDC FDA, 
and ACF for Small Business Innovation Research Grant Applications 
(Parent SBIR [R43/R44]).
    Time and Date: 8:00 a.m.-5:00 p.m., EDT, July 18, 2017 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the secondary 
review, discussion, and evaluation of applications received in response 
to FOAs ``Research Grants for Preventing Violence and Violence Related 
Injury (R01)'', CE17-003; and ``PHS 2016-02 Omnibus Solicitation of the 
NIH, CDC FDA, and ACF for Small Business Innovation Research Grant 
Applications (Parent SBIR [R43/R44])''.
    Contact Person for More Information: Gwendolyn H. Cattledge, Ph.D., 
M.S.E.H., Deputy Associate Director for Science, National Center for 
Injury Prevention and Control, CDC, 4770 Buford Highway NE., Mailstop 
F-63, Atlanta, Georgia 30341, Telephone (770) 488-1430.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and

[[Page 26934]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-12123 Filed 6-9-17; 8:45 am]
 BILLING CODE 4163-18-P